Company: MYGN
Filing Date: 2025-04-09
Form Type: DEF 14A
Source: 0000899923-25-000028
Chunk: 66

Company: MYRIAD GENETICS INC
Filing Date: 2025-04-09
Form: DEF 14A
Chunk 66
---
 connection with these new appointments, we entered into an amended and restated employment agreement with Mr. Raha (the "Raha Employment Agreement") and a new employment agreement with Mr. Verratti (the “Verratti Employment Agreement”), details of which are disclosed below and in the Current Report on Form 8-K filed by us on February 24, 2025. 46

#### Compensation and Human Capital Committee Report
In March 2025, the Compensation and Human Capital Committee of the Board reviewed and discussed the Compensation Discussion and Analysis required by Item 402(b) of Regulation S-K, which appears elsewhere in this proxy statement, with our management. Based on this review and discussion, the Compensation and Human Capital Committee has recommended to the Board that the Compensation Discussion and Analysis be included in this proxy statement.

MEMBERS OF THE COMPENSATION AND HUMAN CAPITAL COMMITTEE:

Heiner Dreismann, Ph.D., Chair

Lee N. Newcomer, M.D.

S. Louise Phanstiel

Daniel M. Skovronsky, M.D., Ph.D.

47

#### Summary Compensation Table
The following table shows the total compensation paid or accrued during the 2024, 2023, and 2022 fiscal years, as indicated, to: (1) each person who served as our Chief Executive Officer or our Chief Financial Officer during the year ended December 31, 2024 and (2) our three next most highly-compensated executive officers during the year ended December 31, 2024, who were serving as executive officers as of December 31, 2024.

| Name and Principal Position              |     |     Fiscal 
       Year |     |     Salary 
        ($) |     | Bonus  ($) (1) |     |       Stock 
      Awards 
     ($) (2) |     | Option         Awards            ($) |     |     Non-Equity 
 Incentive Plan 
   Compensation 
        ($) (3) |     |    All Other 
 Compensation 
      ($) (4) |     |   Total ($) |
| Paul J. Diaz                             
 President and Chief Executive Officer(5) |     |       2024 |     | $1,120,875 |     |             $— |     | $11,113,514 |     |                                   $— |     |     $1,356,750 |     |      $39,461 |     | $13,630,599 |
| 2023                                     |